Canopy Growth Corporation
General ticker "CGC" information:
- Sector: Health Care
- Industry: Drug Manufacturers - Specialty & Generic
- Capitalization: $397.0M (TTM average)
Canopy Growth Corporation does not follow the US Stock Market performance with the rate: -19.6%.
Estimated limits based on current volatility of 3.5%: low 0.51$, high 0.54$
Factors to consider:
- Total employees count: 1128 (+17.5%) as of 2026
- US accounted for 13.8% of revenue in the fiscal year ended 2024-03-31
- Top business risk factors: Regulatory and compliance, Capital shortage, Integration failure, Agricultural crop failure, Currency fluctuations
- Current price 14.6% below estimated low
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2026-03-31 to 2028-03-30
- 2026-03-31 to 2027-03-31 estimated range: [0.59$, 1.31$]
- 2027-03-31 to 2028-03-30 estimated range: [0.53$, 1.18$]
Short-term CGC quotes
Long-term CGC plot with estimates
Financial data
| YTD | 2026-03-31 |
|---|---|
| Operating Revenue | CA$284.60MM |
| Operating Expenses | CA$357.71MM |
| Operating Income | CA$-73.11MM |
| Non-Operating Income | CA$-189.78MM |
| Interest Expense | CA$38.19MM |
| Income(Loss) | CA$-262.88MM |
| Taxes | CA$0.02MM |
| Net Income(Loss)* | CA$-262.91MM |
| Stockholders Equity | CA$697.59MM |
| Inventory | CA$154.12MM |
| Assets | CA$1,118.73MM |
| Operating Cash Flow | CA$-63.81MM |
| Capital expenditure | CA$5.95MM |
| Investing Cash Flow | CA$-21.35MM |
| Financing Cash Flow | CA$332.41MM |
| Earnings Per Share** | CA$-0.88 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.